Basic Information
Basic information for SNHG14-284-239aa
Peptide Name SNHG14-284-239aa
Genome Position chr15:25232235-25232331,25232711-25232755,25234575-25234619,25236409-25236453,25239650-25239781,25240168-25240212,25241559-25241690,25242072-25242116,25243427-25243557[+]
Species Human
Peptide Sequence MALDQCLSARFPAPDALKLKPFLAPWSPALSCVSSSAQVVPPALSGIVSSSKQVGSLALTDRVSSATQDIPLALTGIDADPGGRLVSGPQAPGQCPSARCSAPSALKLRPFLAPWCPALSCVSFSTQVGPLALTDIDDETGGRLPLGPLFLGQCPSARCSAPGVLKLQPFLVPQSSALSCVSSSTQEGPLALTGIDGETGGRLVLGLLFLGQWPSACCPAPEALKLRPFLTPWSPALAV
Peptide Length 239
Unique No (SNHG14-225-239aa,SNHG14-244-239aa,SNHG14-294-239aa,SNHG14-331-239aa)
Grand Average of Hydropathicity 0.3289
Relative Molecular Mass 28681.99
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000663359;SNHG14-284
Transcript Length 4255
Coding Ability 0.4604
DNA Sequence Corresponding to Peptide ATGGCCCTGGACCAGTGTCTGTCAGCCAGGTTCCCAGCCCCCGATGCGCTGAAGCTCAAGCCTTTCCTGGCACCCTGGTCTCCTGCACTGAGCTGTGTGAGCTCTTCGGCCCAAGTGGTCCCCCCGGCCTTAAGCGGCATAGTGAGCTCTTCCAAACAGGTGGGCTCCCTAGCATTGACCGACAGAGTGAGCTCTGCCACCCAGGACATCCCCCTGGCATTGACTGGCATAGATGCTGACCCTGGAGGAAGACTTGTGTCGGGCCCCCAGGCCCCAGGCCAGTGTCCATCAGCCAGGTGCTCAGCTCCCAGTGCGCTGAAGCTCAGACCCTTCCTGGCACCCTGGTGTCCAGCACTGAGCTGTGTGAGCTTTTCCACCCAGGTGGGCCCCCTGGCATTGACCGACATAGATGATGAGACTGGAGGAAGACTTCCATTGGGCCCACTTTTCCTGGGCCAGTGTCCATCAGCCAGGTGCTCAGCCCCTGGTGTACTGAAGCTCCAGCCTTTCCTGGTGCCCCAGTCTTCTGCACTAAGCTGTGTGAGCTCTTCCACCCAGGAGGGCCCCTTGGCATTGACTGGCATAGATGGTGAGACGGGAGGAAGACTTGTGTTGGGCCTGCTGTTCCTGGGCCAGTGGCCATCAGCCTGTTGCCCAGCCCCTGAGGCGCTGAAGCTCAGGCCCTTCCTCACACCCTGGTCTCCTGCACTAGCTGTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :